Cannabinoid-based medicines in clinical care of chronic non-cancer pain: an analysis of pain mechanism and cannabinoid profile
Aim: Among treatments for chronic non-cancer pain (CNCP), cannabinoid-based medicines (CBMs) have become extremely popular. Evidence remains modest and limited primarily to delta-9-tetrahydrocannabinol (THC) for neuropathic pain; nevertheless, the use of various CBMs, including cannabidiol (CBD) to...
Saved in:
Main Authors: | Lucile Rapin (Author), Maria Fernanda Arboleda (Author), Erin Prosk (Author), Charles Sun (Author), Alain Watier (Author), Michael Dworkind (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The model of care at a leading medical cannabis clinic in Canada
by: Erin Prosk, et al.
Published: (2021) -
Synthetic cannabinoid for the treatment of severe chronic noncancer pain in children and adolescents
by: Naiyi Sun, et al.
Published: (2022) -
Targeting the endogenous cannabinoid system to treat chronic neuropathic pain
by: Benjamin K Lau, et al.
Published: (2014) -
The Role of Cannabinoid Receptors in the Descending Modulation of Pain
by: Francesco Rossi, et al.
Published: (2010) -
Cannabinoids and Pain: New Insights From Old Molecules
by: Sonja Vučković, et al.
Published: (2018)